Norbert Odolczyk

Warsaw, MZ, Poland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications

Fluoroquinolones as the linchpin of tuberculosis therapy: contrasting efficacy and resistance profiles in Mycobacterium tuberculosis versus Mycobacterium abscessus.

Fluoroquinolones as the linchpin of tuberculosis therapy: contrasting efficacy and resistance profiles in Mycobacterium tuberculosis versus Mycobacterium abscessus.

Journal: Frontiers in cellular and infection microbiology
Published: March 19, 2026

Peptide-Based Inhibitors of Protein-Protein Interactions (PPIs): A Case Study on the Interaction Between SARS-CoV-2 Spike Protein and Human Angiotensin-Converting Enzyme 2 (hACE2).

Peptide-Based Inhibitors of Protein-Protein Interactions (PPIs): A Case Study on the Interaction Between SARS-CoV-2 Spike Protein and Human Angiotensin-Converting Enzyme 2 (hACE2).

Journal: Biomedicines
Published: September 06, 2024

Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the ΔF508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator.

Design of Crotoxin-Based Peptides with Potentiator Activity Targeting the ΔF508NBD1 Cystic Fibrosis Transmembrane Conductance Regulator.

Journal: Journal of molecular biology
Published: September 29, 2022

Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2.

Improvement of native structure-based peptides as efficient inhibitors of protein-protein interactions of SARS-CoV-2 spike protein and human ACE2.

Journal: Frontiers in molecular biosciences
Published: June 30, 2022

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice.

Systemic bis-phosphinic acid derivative restores chloride transport in Cystic Fibrosis mice.

Journal: Scientific reports
Published: August 01, 2021

Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor.

Native Structure-Based Peptides as Potential Protein-Protein Interaction Inhibitors of SARS-CoV-2 Spike Protein and Human ACE2 Receptor.

Journal: Molecules (Basel, Switzerland)
Published: March 08, 2021

Mapping Protein-Protein Interactions of the Resistance-Related Bacterial Zeta Toxin-Epsilon Antitoxin Complex (ε₂ζ₂) with High Affinity Peptide Ligands Using Fluorescence Polarization.

Mapping Protein-Protein Interactions of the Resistance-Related Bacterial Zeta Toxin-Epsilon Antitoxin Complex (ε₂ζ₂) with High Affinity Peptide Ligands Using Fluorescence Polarization.

Journal: Toxins
Published: May 14, 2016

Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.

Rattlesnake Phospholipase A2 Increases CFTR-Chloride Channel Current and Corrects ∆F508CFTR Dysfunction: Impact in Cystic Fibrosis.

Journal: Journal of molecular biology
Published: March 04, 2016

The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanoma.

The clinical response to vemurafenib in a patient with a rare BRAFV600DK601del mutation-positive melanoma.

Journal: BMC cancer
Published: April 24, 2014

Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.

Molecular modelling approaches for cystic fibrosis transmembrane conductance regulator studies.

Journal: The international journal of biochemistry & cell biology
Published: February 18, 2014

Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.

Discovery of novel potent ΔF508-CFTR correctors that target the nucleotide binding domain.

Journal: EMBO molecular medicine
Published: March 19, 2013
Showing 1-11 of 11

Last Updated: 09/26/2026